REV-ERB agonism improves liver pathology in a mouse model of NASH is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0.918. It has been cited 32 times, with 28 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.524
From this paper's citation signal
Citation Network Contribution
0.393
From 22 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 28 citers.
U.S. Department of Defense
Grant: W81XWH1910632
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1F32DK105845
NIDDK NIH HHS
Grant: F32 DK105845
National Institutes of Health
Grant: 5F32DK105845-02
Investigating Synthetic Ligands for the Treatment of NASH
FWCI
2.19
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals